dc.contributor.author | EŞKAZAN, Ahmet Emre | |
dc.contributor.author | Ercaliskan, Abdulkadir | |
dc.date.accessioned | 2021-03-03T13:34:44Z | |
dc.date.available | 2021-03-03T13:34:44Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Ercaliskan A., EŞKAZAN A. E. , "Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia", FUTURE ONCOLOGY, cilt.16, sa.3, ss.4425-4428, 2020 | |
dc.identifier.issn | 1479-6694 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_34daec69-9457-4f8a-ac64-7d16e31f5616 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/39734 | |
dc.identifier.uri | https://doi.org/10.2217/fon-2020-0006 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.title | Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia | |
dc.type | Makale | |
dc.relation.journal | FUTURE ONCOLOGY | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 4425 | |
dc.identifier.endpage | 4428 | |
dc.contributor.firstauthorID | 2275923 | |